When considering a weight loss medication — or any medication — it’s normal to wonder when the effects will kick in.

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said ...

Novo Nordisk is replacing Chief Executive Officer Lars Fruergaard Jorgensen amid increased competition for its Wegovy obesity shots. The move follows a 53% decline in its share price over the past 12 ...

A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s ...

Patients taking Eli Lilly’s drug to combat obesity, Zepbound, lost more weight than those who took Novo Nordisk’s Wegovy in a ...

Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users. In both ...

Novo Nordisk's Q1 results show a dramatic expansion in sales beyond the US. Nevertheless, issues remain, and its outlook for ...

Wegovy's list price before insurance is $1,349 for a month's supply, while Zepbound's is $1,086. That decision by one of the nation's largest PBMs triggered fears of a price war in the weight loss ...

Pedersen and Maggie Fick COPENHAGEN/LONDON (Reuters) -Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the ...